Joseph A. Boystak, MPH ’77
CEO Brightwaters Capital
- At a Glance
-
Leadership
- Dean MacKenzie
- Deans
- Chairs
- Faculty Senate
- Student Assembly
- Staff Assembly
-
Health Advisory Board
-
Board Members
- Alfred Sommer, MD, MHS '73
- Andrea D. Willis, MD, MPH '99, FAAP
- Ashok Agarwal, MPH '84
- Brian D. Crawford, PhD '82
- Caroline Popper, MD, MPH '90
- Catharine C. Dorrier
- Chereé M. Haswell Johnson, JD
- Christopher Anzalone
- Christopher I.M. Jones
- Colleen Cutcliffe, PhD
- Constance R. Caplan, MA '78
- Dave Hickey
- Dean Goodermote
- Deborah Levy, PhD '97, MPH
- Douglass B. Given, MD
- Edward J. Ludwig, MBA
- Faith Thomas, JD
- George L. Bunting, Jr.
- Hsien-Hsien Lei, PhD '98
- Ira M. Rutkow, MD, PhD '81, MPH '78
- Irene C. Frary, MBA
- Joseph A. Boystak, MPH '77
- Karl P. Ronn
- Kathleen Ludwig
- Kelvin A. Baggett, MD, MPH '05
- Manfred Eggersdorfer, PhD
- Margaret Conn Himelfarb, MPH '04
- Marion Bergman, MD
- Michael J. Klag, MD, MPH '87
- Michael Kullman
- Nikos Pavlidis, MSc
- Pamela Hoehn-Saric
- Randolph "Randy" Gordon, MD, MPH '88
- Ravi Kavasery, MD
- Robert Carr, MD, MPH '86, FACPM
- Robert J. Abernethy, '62
- Roberta L. Schwartz, PhD, MHS '94
- Rodrigo A. Sierra, MBA
- Roger C. Lipitz
- Shale D. Stiller, MLS '77
- Sister Charlotte Kerr, RN, BSN, MPH
- Stephen G. Moore, MD, MPH '93
- Suprotik Basu, MHS `02
- Thomas McCann
- William C. Clarke III
- William Flumenbaum
- Committee Structure
- Philanthropic Impact
-
Board Members
-
Student Life
- Campus
- Baltimore
- Strategic Priorities
- Inclusion, Diversity, Anti-Racism, and Equity (IDARE)
-
History
- Timeline
- Deans of the School
- Mike Bloomberg
-
Heroes of Public Health
- Abel Wolman
- Abraham Lilienfeld, MD, MPH
- Alexander Langmuir, MD, MPH
- Anna M Baetjer, ScD
- Annelies S. Zachary, MD, MPH
- Annelies S. Zachary, MD, MPH
- Annik A. Rouillon, MD, MPH
- B. Frank Polk, MD, MSc
- Bernard Roizman, ScD
- Bill Gates, Sr.
- Carroll E. Palmer, MD, PhD
- Elmer V. McCollum, PhD
- Emanuel Kaplan, ScD
- Ernest L. Stebbins, MD, MPH
- Frank Hurley
- Fred Soper, DrPH, MPH
- Frederik Bang, MD
- George Comstock, MD, DrPH, MPH
- George W. A. Dick, MBChB, MPH
- Gilbert Otto, ScD
- Harry G. Day, ScD
- Helen Abbey, ScD
- Henry E. Sigerist, MD, PhD
- Herald R. Cox, ScD
- Jae-Moe Yang, MD, MPH, DMSc
- Jo Eirik Asvall, MD, MPH
- John H. Hanks, PhD
- Justin Andrews, ScD
- Kenneth Maxcy, DrPH
- Leo Kaprio, MD, DrPH, MPH
- Leroy E. Burney, MD, MPH
- Lewis Robbins, MD, MPH
- Lloyd E. Rozeboom, ScD
- Margaret Merrell, ScD
- Mo-Im Kim, DrPH, MPH
- Nowshir Jungalwalla, MD, MPH
- Paul V. Lemkau, MD
- Raymond Pearl, PhD
- Robert W. Hegner, PhD
- Ross Gauld, DrPH MPH
- Russell E. Morgan, MD
- Sushila Nayar, MBBS, DrPH, MPH
- Timothy Danforth Baker, MD, MPH ’54
- Virginia Apgar, MD, MPH
- William Henry Welch, MD
- William W. Cort, PhD
- Yolanda Nashio
- Centennial 2016
- What is Public Health?

Joseph A. Boystak, MPH ’77, is CEO of Brightwaters Capital. He is a senior investment banker, venture capitalist, and serial company co-founder in the global health care, life sciences, and technology sectors with over 35 years of experience. He was founding managing partner of Health2047 Capital Partners and founding managing director of Global Life Sciences Investment Banking at Jefferies. As an investment banker, he has executed transactions in every sector of health care/life sciences on a global scale including all forms of equity, convertible and debt securities, mergers and acquisitions, corporate partnering, and strategic advisory.
He served as co-founder, investor, board member, and senior executive of spin out companies from top-tier universities and academic medical centers, including Exosome Diagnostics; Bruin Biometrics; Macro Biologics; PapiVax; GenoSpace; PAIGE.AI; and Balboa Geolocation. He is a named co-inventor on five U.S. and European issued patents for the SEM Scanner an FDA-approved, first-in-class medical device technology.
He currently serves on the following boards: Dr.Evidence (chairman); Balboa Geolocation (chairman/CEO); Omelette LLC; SoCalBio; Terasaki Institute; and the Johns Hopkins Bloomberg School of Public Health.
He is a frequent speaker at leading health care industry and investor conferences and has been a member of the Financial Innovation Lab at the Milken Institute and Faster Cures.
He earned his BA at Boston University, MHS at Johns Hopkins Bloomberg School of Public Health, and completed executive education at the Wharton School. He is a registered representative with FINRA and holds Series 7 and 63 securities licenses.